Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

HONG KONG, February 15 /PRNewswire/ --

OrbusNeich's Genous(TM) Bio-engineered R stent(TM) is feasible and safe for use in acute myocardial infarction (AMI) patients, according to a paper published in the American Heart Journal (2008; Vol. 155, Issue 1: 128-132).

The paper, based on a study of 120 acute ST-elevation myocardial infarction (STEMI) patients who received a Genous stent, reports there was no incidence of late thrombosis and that the revascularization rate of 2.5% at six months is highly acceptable when compared to published primary percutaneous coronary intervention (PCI) rates for bare metal stents. The paper also highlighted the low rate of major adverse cardiac events (MACE): 4.2% at 30 days and 5.8% at six months.

LONDON, February 15 /PRNewswire/ -- Prospects new Managing Director will be Vincent McDonnell, currently Director of Learning at CfBT Education Trust. He will take over in his new post at the end of March.

Vincent worked in senior positions in Birmingham, Sheffield and then Staffordshire Local Education Authorities, before moving to the London Borough of Richmond as Chief Education Officer in February 1998.

Then, in April 2000, he moved to Cambridge Education, to lead the outsourced education service in Islington, turning around what had been identified as a failing service into what was subsequently identified as one of the most improved Authorities in the country.

BARCELONA , Mobile World Congress, February 15 /PRNewswire/ -- Launched in 2007, the R&S CMW270 WiMAX communication tester from Rohde & Schwarz now offers the capability to emulate a base station (signaling mode). This capability means utmost flexibility and test depth. Plus, the measurement speed of the instrument is up to ten times higher than that of existing test solutions. This results in maximum throughput in the production of WiMAX chipsets and mobile stations.

HONG KONG, February 15 /PRNewswire/ --

- Innovative Hydrogen-Powered Radio-Controlled Car Leads Green Toy Revolution

Wah Shing Toys Co., Ltd. (Wah Shing), one of the world's largest toy manufacturers, today announced that its H2Go hydrogen-powered RC car has won the Toy Innovation 2008 Award in the Electronics and Technology category at this year's International Toy Fair in Nuremburg. The H2Go car, manufactured by Wah Shing, uses technology invented by Horizon Fuel Cell Technologies ("Horizon") the leading producer of consumer-oriented fuel cell technology and is being marketed by the renowned Corgi International.

SYDNEY, Australia, February 15 /PRNewswire/ -- In the news release, "Scholarships for Indigenous Australians: Education is the Key" issued on 15 Feb 2008 04:22 GMT, by Mary MacKillop Foundation Australia over PR Newswire, we are advised by a representative of the company that four additional paragraphs should be included in the beginning of the release. Complete, corrected release follows:

February 13 was a momentous day in Australia as the Prime Minister formally apologised to members of the Indigenous stolen generation. He did this on behalf of the current Australian government and nation apologising for the policy of previous Australian Governments of forcibly removing Indigenous children from their parents.

MELBOURNE, Australia, February 15 /PRNewswire/ --

In a landmark study electronically published today in the American Journal of Respiratory and Critical Care Medicine, a blood test for detecting TB infection, QuantiFERON(R)-TB Gold (QFT(TM)), has been shown to be six times more accurate than the conventional tuberculin skin test (TST) at predicting which tuberculosis (TB)-exposed individuals will go on to develop TB disease. This study has important implications for the worldwide effort to eradicate TB, as accurately indentifying TB-infected individuals allows health authorities to treat them before they develop disease, and the greater accuracy of the new test makes this more efficient as well as cheaper and safer.